Company | Veralto Corporation |
Ticker | VLTO (NYSE) |
Upcoming Earnings | Q2 2026 (expected late July / early August 2026) |
Last Earnings | Q1 2026 — April 29, 2026 (beat on EPS and revenue; FY guidance raised) |
Preparation Date | July 28, 2026 |
Analyst Coverage | Water Quality & Product Quality / Industrial Technology |
Key Takeaway: The setup into Q2 2026 is modestly constructive — consensus sits at a reasonable bar with core growth expected to accelerate sequentially, but the biggest swing factor is whether PQI can recover from its Q1 weakness in discrete industrial end markets (automotive, textiles, building materials) while Water Quality sustains its mid-single-digit momentum.
Heading into Q2 2026, the bar for VLTO looks achievable but not easy. Consensus expects revenue of ~$1.455B (+6.1% YoY) and adjusted EPS of ~$1.008, both implying sequential acceleration from Q1's $1.422B / $1.07 print. Management guided for core growth to accelerate as the year progresses and raised full-year adjusted EPS guidance to $4.20–$4.28 after Q1, signaling confidence in the trajectory — a tone that is notably more constructive than the cautious posture at Q4 2025. Estimate revisions have been modestly positive since the Q1 print, with FY2026 EPS consensus moving from $4.250 to $4.255 and Q2 EPS from $1.000 to $1.008, suggesting the Street is broadly aligned with guidance rather than running ahead of it. The stock has rallied ~10% since the Q1 earnings date (from ~$85.60 to ~$94.28 as of July 28), outperforming XLI, which means some beat is already priced in and the reaction function is asymmetric — a miss or guidance hold would likely be punished more than a beat would be rewarded. The key wildcard is PQI segment recovery: management flagged Q2 PQI margins would be impacted by mix, and if the discrete industrial end-market weakness (automotive, textiles, building materials) persists longer than expected, PQI core growth could again disappoint vs. the ~2.5% consensus, dragging the overall core growth print below the ~3.5% expectation.
Key Takeaway: Consensus is a moderate bar — not stretched, but not low either. Core sales growth (~3.5% consensus) is the bigger swing factor given management's sequential acceleration narrative; adjusted EPS of ~$1.008 is well-supported by the raised FY guide and pricing strength.
KPI | Q1 2026 Actual (Last Quarter) | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | FY2026 Guidance (Raised Q1) | Consensus vs. Guidance |
Total Revenue ($B) | $1.422B | $1.371B | $1.455B | +6.1% | $5.875B (FY cons.) | N/A — no Q2 rev. guidance |
Core Sales Growth (%) | 1.9% | 4.8% | ~3.5% | ~(130 bps) vs. PY | Low-to-mid single digit (FY) | Within guidance range |
Core Sales Growth — Water Quality (%) | 3.8% | 5.0% | ~4.2% | ~(80 bps) vs. PY | Mid-single digit (segment) | Within guidance range |
Core Sales Growth — PQI (%) | -1.0% | 4.6% | ~2.5% | ~(210 bps) vs. PY | Recovery expected (mgmt.) | N/A — no segment guidance |
Adj. EPS — Diluted (Operating) ($) | $1.07 | $0.93 | $1.008 | +8.4% | $4.20–$4.28 (FY) | ~(0.5%) below midpoint |
Free Cash Flow ($M) | $170M | $323M | $309M | -4.3% vs. PY | >100% conversion (FY) | N/A — no Q2 FCF guidance |
Sources: Visible Alpha Consensus and Actuals Data. All consensus figures as of July 28, 2026. Q2 2026 core growth segment splits are derived from VA consensus. FY2026 guidance range per Q1 2026 earnings call (April 29, 2026). FCF Q2 2025 actual = $323M; Q2 2026 consensus = $309M.
Top 2 KPIs: (1) Adjusted EPS — Diluted (Operating) | (2) Core Sales Growth (%)
Quarter | Adj. EPS Reported | Adj. EPS Consensus | EPS Surprise % | EPS Result | Core Growth Reported | Core Growth Consensus | Core Growth Surprise | Core Growth Result |
Q2 2024 | $0.85 | $0.798 | +6.5% | BEAT | 3.8% | N/A | N/A | N/A |
Q3 2024 | $0.89 | $0.850 | +4.7% | BEAT | 4.6% | N/A | N/A | N/A |
Q4 2024 | $0.95 | $0.894 | +6.3% | BEAT | 4.6% | N/A | N/A | N/A |
Q1 2025 | $0.95 | $0.867 | +9.6% | BEAT | 7.8% | N/A | N/A | N/A |
Q2 2025 | $0.93 | $0.885 | +5.1% | BEAT | 4.8% | 4.4% | +40 bps | BEAT |
Q3 2025 | $0.99 | $0.950 | +4.2% | BEAT | 5.1% | 4.7% | +40 bps | BEAT |
Q4 2025 | $1.04 | $0.979 | +6.2% | BEAT | 1.6% | 2.5% | -90 bps | MISS |
Q1 2026 | $1.07 | $1.006 | +6.4% | BEAT | 1.9% | 1.2% | +70 bps | BEAT |
Pattern: VLTO has beaten adjusted EPS consensus in all 8 of the last 8 quarters, with an average surprise of ~+6%. Core sales growth has beaten in 3 of the 4 quarters where consensus data is available, with the lone miss in Q4 2025 (1.6% vs. 2.5% expected) driven by shipping day headwinds. The consistent EPS beat pattern reflects strong pricing discipline and VES-driven cost execution, but the core growth record is more mixed, making revenue the higher-risk line.
Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Guidance moved meaningfully higher after Q1 2026 — full-year adjusted EPS raised by ~$0.09 at the midpoint — and management tone shifted from cautious (Q4 2025) to confident, citing pricing at the high end, strong order books, and broad operational execution. No post-Q1 guidance revisions have been issued.
Metric | Initial Guidance (Q4 2025 Earnings Call, Feb 4, 2026) | Revised Guidance (Q1 2026 Earnings Call, Apr 29, 2026) | Current Consensus (Jul 28, 2026) | Note |
FY2026 Adj. EPS | $4.10–$4.20 (mid-to-high single-digit growth) | $4.20–$4.28 | $4.255 | ↑ Raised at Q1 2026 earnings; driven by Q1 beat, pricing at high end, strong order books entering Q2 |
FY2026 Core Sales Growth | Low-to-mid single digit (YoY) | Acceleration expected as year progresses (no new range) | ~3.9% | Tone more confident; sequential acceleration narrative intact |
FY2026 FCF Conversion | >100% net income conversion | Unchanged | $1.038B (FY cons.) | No change; strong conversion track record maintained |
Tariff Headwinds | 2025 tariff headwinds to roll off in H2 2026 | Confirmed; new Section 232 impact baked into guidance; overall impact “much smaller” | N/A | Tailwind building into H2 2026 as prior-year pricing actions roll over |
Cost Optimization Program | Not announced | New program initiated; ~50% of run-rate savings in 2027, full run-rate in 2028; no 2026 P&L benefit | N/A (2027+ benefit) | ↑ New EPS growth lever; actions concentrated in Q4 2026; slight PQI bias but broad-based |
PQI Segment Margins (Q2) | Not specifically guided | Mix headwind flagged for Q2; recovery expected in H2 2026 and 2027 | N/A | Watch: Q2 PQI margin is a known risk; tariff roll-off provides H2 tailwind |
Management tone has shifted decisively from the cautious, "judicious" posture at Q4 2025 to a confident, execution-focused stance at Q1 2026. The guidance raise was driven by three factors: (1) Q1 operational outperformance, (2) pricing at the high end of the range, and (3) strong order books entering Q2. The new cost optimization program — not in the Q4 2025 script — adds a credible 2027–2028 EPS growth lever that the Street is beginning to model. No post-Q1 guidance updates have been issued, meaning the Q1 call remains the baseline.
Sources: VLTO Q4 2025 Earnings Call Transcript (Feb 4, 2026); VLTO Q1 2026 Earnings Call Transcript (Apr 29, 2026); Visible Alpha Consensus Data.
Key Takeaway: Estimates have moved modestly higher since the Q1 print, tracking guidance rather than diverging from it. The gap between consensus and guidance midpoint is narrow (~−0.5% for FY EPS), suggesting limited cushion but also limited risk of a guidance-driven cut.
KPI (Period) | Estimate (May 5, 2026 — 5 Days Post Q1 Print) | Current Consensus (Jul 28, 2026) | Estimate Δ (%) | Initial Guidance (Q4 2025 Call) | Current Guidance (Q1 2026 Call) | Guidance Δ | Consensus vs. Guidance (%) |
Adj. EPS — Q2 2026 | $1.000 | $1.008 | +0.8% | N/A (no Q2 EPS guidance) | N/A | N/A | N/A |
Adj. EPS — FY2026 | $4.250 | $4.255 | +0.1% | $4.10–$4.20 (mid. $4.15) | $4.20–$4.28 (mid. $4.24) | +$0.09 at midpoint | +0.4% above midpoint |
Adj. EPS — FY2027 | $4.655 | $4.675 | +0.4% | N/A | N/A | N/A | N/A |
Total Revenue — Q2 2026 ($B) | $1.451B | $1.455B | +0.3% | N/A (no Q2 rev. guidance) | N/A | N/A | N/A |
Total Revenue — FY2026 ($B) | $5.874B | $5.875B | +0.0% | N/A | N/A | N/A | N/A |
Core Sales Growth — Q2 2026 (%) | ~3.4% | ~3.5% | +0.1 pp | Low-to-mid single digit (FY) | Acceleration expected (no Q2 range) | N/A | Within guidance range |
Free Cash Flow — FY2026 ($B) | $1.039B | $1.038B | -0.1% | >100% conversion | Unchanged | No change | Consistent with guidance |
Estimates have been remarkably stable since the Q1 print, with FY2026 EPS moving only +$0.005 and Q2 EPS moving +$0.008. This stability reflects a Street that is broadly aligned with management's raised guidance rather than running ahead of it. The FY2027 EPS drift higher (+$0.020) is more notable and likely reflects early modeling of the cost optimization program savings. The narrow consensus-vs.-guidance gap on FY EPS (~+0.4% above midpoint) means there is limited cushion if Q2 disappoints, but also limited risk of a guidance-driven cut if results are in-line.
Source: Visible Alpha Consensus and Actuals Data. Baseline as of May 5, 2026 (5 trading days post Q1 2026 earnings).
Key Takeaway: VLTO has rallied ~10.1% since the Q1 2026 earnings date (Apr 28 close: $85.60 → Jul 28: $94.28), outperforming XLI (+7.2%) but lagging SPY (+3.9%) — the outperformance vs. industrials reflects the guidance raise and cost optimization program announcement, while the underperformance vs. SPY reflects the market's continued skepticism about VLTO's single-digit growth profile relative to higher-growth tech-driven names.
VLTO vs. XLI vs. S&P 500 (SPY) — Indexed to 100 at April 28, 2026 (Q1 2026 Earnings Date). Source: Stock Price Data.
Stock Performance Detail (Apr 28 – Jul 28, 2026):
Name | Apr 28 Close | Jul 28 Close | Return |
VLTO | $85.60 | $94.28 | +10.1% |
XLI (Industrials ETF) | $170.98 | $183.20 | +7.1% |
SPY (S&P 500) | $711.69 | $739.09 | +3.9% |
The stock's post-Q1 rally was driven primarily by the guidance raise and the new cost optimization program announcement, which directly addressed the market's Q4 2025 concern about growth deceleration. The stock peaked near $94–$95 in early July before pulling back modestly, suggesting the market is now in a "wait and see" mode ahead of Q2 results. With the stock up ~10% since earnings and trading near recent highs, the reaction function into Q2 is asymmetric: a beat with guidance raise would likely produce a modest positive reaction, while a miss or guidance hold could see a sharper pullback given the elevated starting point. The XLI outperformance is durable if the cost optimization program delivers as promised in 2027–2028.
Source: Stock Price Data (Yahoo Finance). XLI used as the industrials sector ETF, appropriate for VLTO's water quality and product quality industrial sub-sector.
Key Takeaway: The most important development since Q1 earnings is the new cost optimization program announced April 29, which adds a credible 2027–2028 EPS growth lever and has been the primary driver of positive sentiment; the secondary watch item is whether the GlobalVision integration is tracking to plan and whether M&A pipeline activity signals another deal before year-end.
Key Takeaway: Peer commentary from Q2 2026 earnings calls (reported in July 2026) is broadly constructive for VLTO — Danaher's acceleration in core growth, Honeywell's industrial automation beat, Badger Meter's sequential water demand recovery, and SGS's high-single-digit food/CPG testing growth all point to improving end-market conditions that should support VLTO's Q2 core growth acceleration narrative. The one cautionary note is Kemira's soft industrial water demand, though that is more relevant to European chemical-intensive industries than VLTO's municipal/CPG mix.
Note: Only commentary from Q2 2026 earnings calls (reporting on the April–June 2026 quarter) is included below. Q1 2025 results or prior-quarter retrospectives are excluded.
Relevance to VLTO: DHR is the closest structural peer — both operate in water quality instrumentation, life sciences filtration, and industrial testing. DHR's core growth trajectory is a direct read-through for VLTO's Water Quality segment demand and broader industrial instrumentation trends.
Relevance to VLTO: HON's Industrial Automation and Process Automation segments overlap with VLTO's industrial end markets (sensing, measurement, process instrumentation). HON's CPG and food/beverage exposure is less direct, but its industrial demand read is relevant.
Relevance to VLTO: BMI is a direct peer in water metering and flow instrumentation for utilities. Its commentary on municipal water demand, utility modernization, and data center water is the most direct read-through for VLTO's Water Quality segment.
Relevance to VLTO: SGS is a global testing, inspection, and certification company with significant food/beverage, CPG, and product quality exposure — directly relevant to VLTO's PQI segment (Videojet, Esko, TraceGains) and its CPG customer base.
Relevance to VLTO: ROP is a diversified industrial technology company with software and niche industrial businesses. Its Neptune water metering business is a direct peer to VLTO's Water Quality segment; its broader software/recurring revenue model is analogous to VLTO's recurring revenue mix.
Relevance to VLTO: Kemira is a water treatment chemicals company serving industrial and municipal customers. Its commentary on industrial water demand and municipal water stability is relevant to VLTO's Water Quality segment, though Kemira's exposure is more European and more chemical-intensive than VLTO's analytics/treatment mix.
Overall Peer Read-Through Summary: The weight of Q2 2026 peer evidence is constructive for VLTO. DHR's core growth acceleration, HON's industrial automation beat and raised guidance, SGS's high-single-digit food/CPG testing growth, and ROP's strong recurring revenue all support VLTO's sequential acceleration narrative. The one area of caution is electronic component cost inflation (flagged by both BMI and HON), which could pressure VLTO's instrument gross margins. Kemira's European industrial weakness is largely idiosyncratic and not a direct read-through for VLTO's more diversified, North America-weighted business.
Sources: DHR Q2 2026 Earnings Call Transcript (Jul 21, 2026); HON Q2 2026 Earnings Call Transcript (Jul 23, 2026); BMI Q2 2026 Earnings Call Transcript (Jul 22, 2026); SGSN SW H1 2026 Earnings Call Transcript (Jul 24, 2026); ROP Q2 2026 Earnings Call Transcript (Jul 23, 2026); KEMIRA FH Q2 2026 Earnings Call Transcript (Jul 17, 2026).
Key Takeaway: No open-market buys or discretionary sells from senior management since Q1 earnings. The only notable transaction is CEO Jennifer Honeycutt's 10b5-1 planned sale of 7,097 shares on July 17 — a pre-scheduled transaction that is obligation-driven and not a discretionary signal. The bulk of July activity is routine director compensation grants (code A), which are non-informative.
Name | Title | Transaction Type | Shares | Date | Note |
Jennifer Honeycutt | President & CEO, Director | 10b5-1 Planned Sale (Code S) | 7,097 shares | Jul 17, 2026 | Pre-scheduled 10b5-1 plan sale; not a discretionary signal. Exercised 7,097 options (Code M) simultaneously. Retains 124,085 shares post-transaction. |
Sameer Ralhan | SVP, Chief Financial Officer | Tax Withholding (Code F) | 3,305 shares | Jul 15, 2026 | Shares withheld for tax obligation on vesting; not a discretionary sale. Retains 53,694 shares. |
Lesley Beneteau | SVP, CHRO | Tax Withholding (Code F) | 423 shares | May 15, 2026 | Shares withheld for tax obligation on vesting; not a discretionary sale. Retains 19,846 shares. |
Bernard M. Skeete | Chief Accounting Officer | Open Market Sale (Code S) | 300 shares | May 1, 2026 | Small open-market sale; de minimis size (300 shares). Retains 4,760 shares. No 10b5-1 flag in data. |
Multiple Directors (9 directors) | Board of Directors | Director Compensation Grant (Code A) | ~1,009–1,834 shares + options each | Jul 15, 2026 | Routine annual director compensation grants (stock + options). Non-informative; standard board compensation cycle. |
The insider picture is clean and non-informative heading into Q2 earnings. The CEO's 10b5-1 sale is pre-scheduled and obligation-driven, not a discretionary signal. The CFO's tax withholding is a routine vesting event. The Chief Accounting Officer's 300-share open-market sale is de minimis. There are no open-market buys from any insider since Q1 earnings, but the absence of buys is not unusual given the stock's ~10% rally since the Q1 print. The broad director compensation grants in July are routine annual awards and carry no informational content. Overall, no insider activity stands out as a meaningful signal in either direction.
Source: Insider Transaction Data (SEC Form 4 filings). Transactions from April 29, 2026 through July 28, 2026.